Verbatim response from ChatGPT
Short answer
- “Bioidentical” hormone replacement therapy (BHRT) can be safe and effective for treating menopausal symptoms when it uses FDA‑approved products (estradiol, micronized progesterone, etc.) and is prescribed and monitored by a clinician.
- Many doctors and major medical organizations caution against custom‑compounded BHRT marketed as “natural” and “safer” because those preparations are not FDA‑regulated and have uncertain dosing, purity and safety.
What “bioidentical” means
- Bioidentical hormones have the same chemical structure as human hormones (for example, 17β‑estradiol and micronized progesterone). Some FDA‑approved products are bioidentical; other marketed hormones (like conjugated equine estrogens or synthetic progestins) are not.
What major medical groups and doctors say
- American College of Obstetricians and Gynecologists (ACOG), The Endocrine Society, The North American Menopause Society (NAMS) and the FDA: they do not endorse marketing claims that compounded BHRT is safer or more effective than FDA‑approved therapies. They recommend using evidence‑based, FDA‑approved hormone products when appropriate and warn about the risks of compounded formulations.
- Clinicians generally support hormone therapy when symptoms substantially impair quality of life and when the benefits outweigh risks for the individual patient. Choice of hormone, dose, route and duration should be individualized.
Key safety points and evidence
- Benefits: effective for hot flashes, night sweats, vaginal dryness, and prevention of bone loss.
- Risks depend on hormone type, dose, route, patient age, and time since menopause: possible increased risks of venous thromboembolism (VTE), stroke, and — with combined estrogen + certain progestins — increased breast cancer risk seen in some studies. Risk is generally lower for younger women who start therapy near menopause (“timing” effect).
- Route matters: transdermal estradiol (patch/gel) appears to have lower VTE risk than oral estrogen because it bypasses first‑pass liver effects. Micronized progesterone may have a different risk profile than synthetic progestins.
- Compounded BHRT: not FDA‑approved, can have variable potency and purity, and often relies on unvalidated saliva tests to dose — medical societies advise caution.
If you’re considering BHRT — practical advice
- Prefer FDA‑approved products unless you have a specific reason a compounded product is necessary. Examples of commonly used FDA‑approved products:
- Estradiol patches/gels: Vivelle‑Dot, Climara, Alora, EstroGel, Divigel (transdermal/gel forms) — transdermal may lower VTE risk.
- Oral estradiol: Estrace.
- Micronized progesterone: Prometrium (often used if a uterus is present to protect the endometrium).
- For men with low testosterone: AndroGel, Testim, Axiron (gels); Depo‑Testosterone or Aveed (injectables) — testosterone therapy also has risks (erythrocytosis, cardiovascular and prostate issues) and should be monitored.
- If a compounded product is needed, use a reputable compounding pharmacy that follows USP standards; ask for certificates of analysis and independent testing.
- Don’t rely on saliva tests for dosing — they’re not supported by evidence. Monitoring typically uses clinical response and, where appropriate, blood tests.
Questions to ask your clinician
- Why do you recommend this particular hormone, dose and route for me?
- Are you prescribing an FDA‑approved product or a compounded formulation? If compounded, why?
- What are the likely benefits for my symptoms and the specific risks for me (blood clots, stroke, heart disease, breast cancer)?
- How will you monitor me (follow‑up schedule, tests, mammograms)? What’s the plan for duration and reassessment?
Bottom line BHRT can be safe and effective when using FDA‑approved, bioidentical (estradiol, micronized progesterone) products under medical supervision. Be cautious about custom‑compounded “bioidentical” products and marketing claims that they are inherently safer or more natural. Talk with a menopause specialist, gynecologist or endocrinologist who can review your individual risks and tailor therapy.